Over USD10 Billion Estimated To Implement 5-Year WHO Draft Programme Of Work 18/01/2018 by Catherine Saez, Intellectual Property Watch Leave a Comment The World Health Organization released a financial estimate for its draft thirteenth general programme of work 2019-2023 on 15 January, after member states asked last autumn how that draft programme was to be financed.
Industry Alliance Report: Companies Invest In AMR R&D, Need More Pull Incentives 18/01/2018 by Intellectual Property Watch 1 Comment An alliance of over a hundred industries seeking to curb antimicrobial resistance launched its first report today. According to the report, a number of companies are heavily investing in research and development, and work to improve access to their diagnostic products and preventing therapies.
Guide To The WHO Executive Board: Access To Medicines, Noncommunicable Diseases, Non-State Actors 15/01/2018 by Catherine Saez, Intellectual Property Watch Leave a Comment The World Health Organization Executive Board meets next week. On the agenda are recommendations of a review group on the WHO Global Strategy on Public Health, Innovation and Intellectual Property, and WHO proposed actions to increase access to affordable and safe medicines and diagnosis. The Executive Board is also expected to consider a report on noncommunicable diseases, new possible organisations to enter into official relationships with WHO, and how to address the global burden of snakebites, including access to treatment.
WHO: New Directors In Leadership Team Selected On Merit First 09/01/2018 by William New, Intellectual Property Watch Leave a Comment The new World Health Organization director general last month announced a range of officials to serve as programme directors, touting the unusual achievement of naming almost all women to add to an overall women’s majority in the senior leadership of the organisation – a first for the UN. Now after some questions arose over the choice of a Russian official to head up efforts against tuberculosis, the WHO defended its choices as fully merit-based, including in an email to Intellectual Property Watch and its sister publication Global Health Policy News.
Medicines Patent Pool Launches Search For Next Director 08/01/2018 by William New, Intellectual Property Watch Leave a Comment A negotiator and fundraiser with extensive experience with the pharmaceutical industry. Those are some of the qualities the next Medicines Patent Pool executive director might have, according to a just-posted job announcement.
WHO’s Revised Work Programme: Evidence-Based Normative Work, Access To Medicines 08/01/2018 by Catherine Saez, Intellectual Property Watch Leave a Comment In a couple of weeks, the World Health Organization will be holding its annual January Executive Board meeting. Delegates will consider the edited version of the draft 13th WHO general programme of work for 2019-2023, published on 5 January. Following comments to the first version of the programme in November, the secretariat produced a more fleshed-out document, emphasizing the WHO’s normative role, in particular evidence-based. The necessity of access to medicines and vaccines has been extended to other products, such as devices and blood products, and mention is made of the WHO Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property.
Top IP-Watch Stories Of 2017: What Do They Tell Us About Multilateral IP Policy? 04/01/2018 by William New, Intellectual Property Watch 1 Comment What IP-Watch stories were readers reading most in 2017, and what does it say about the state of global intellectual property policy? In this article, we look at the most-trafficked stories of last year, and make a few assumptions. Asia, Europe, trade, health. These were the top targets of interest to readers among our offerings. Interestingly, despite all the sound and fury in Washington, our coverage there was not at the top of the list. Even more interestingly, neither was our extensive and world-leading coverage of the World Intellectual Property Organization.
London Declaration Report Shows Progress But More Needed Against Neglected Tropical Diseases 15/12/2017 by Catherine Saez, Intellectual Property Watch Leave a Comment A newly released report by the wide-ranging joint London Declaration initiative to fight neglected tropical diseases shows progress in elimination of diseases and the number of people treated. However, in order to reach universal health coverage, efforts have to be intensified, according to the World Health Organization director general. The pharmaceutical industry, meanwhile, said it is ready to live up to its pledge made five years ago and expand donations programmes.
Former Medicines Patent Pool Head Greg Perry Joins Pharmaceutical Industry 15/12/2017 by Catherine Saez and William New, Intellectual Property Watch Leave a Comment A day after Greg Perry resigned as executive director of the Medicines Patent Pool, the pharmaceutical industry announced today that he will join the Geneva-based International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) as an assistant director general.
Greg Perry Resigns As Director Of Medicines Patent Pool 14/12/2017 by William New, Intellectual Property Watch 1 Comment After nearly five years as the executive director of the Medicines Patent Pool, Greg Perry has stepped down with little notice. [Update: the next day, it was announced that he has joined the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) in Geneva.]